Main Profile

At A Glance

A Comparison of OnabotulinumtoxinA and Topiramate for the Treatment of Chronic Migraine

This multi-center pilot study compared the efficacy of onabotulinumtoxinA with topiramate (a Food and Drug Administration approved and widely accepted treatment for prevention of migraine) in individuals with chronic migraine (CM).
Length: 08:14

Contact

Questions about A Comparison of OnabotulinumtoxinA and Topiramate for the Treatment of Chronic Migraine

Want more info about A Comparison of OnabotulinumtoxinA and Topiramate for the Treatment of Chronic Migraine? Get free advice from education experts and Noodle community members.

  • Answer

Ask a New Question